VYNE Therapeutics  logo
VYNE Therapeutics VYNE
$ 2.5 0.0%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

VYNE Therapeutics Total Liabilities 2011-2024 | VYNE

Annual Total Liabilities VYNE Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
8.95 M 9.34 M 18.4 M 56.2 M 10.7 M 9.55 M 124 M 71.5 M 59.8 M - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
124 M 8.95 M 40.9 M

Quarterly Total Liabilities VYNE Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
12.7 M 11.8 M 8.95 M 7.76 M 7.69 M 8.83 M 9.34 M 6.84 M 6.84 M 8.59 M 18.4 M 22.4 M 59.1 M 56.3 M 56.2 M 56.2 M 56.2 M 56.2 M 63.6 M 63.6 M 63.6 M 63.6 M 9.55 M 9.55 M 9.55 M 9.55 M 14.6 M 14.6 M 14.6 M 14.6 M 12.5 M - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
63.6 M 6.84 M 26.9 M